Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modelo: 1038915-60-4
Marca: DM
Appearance: Powder
Paquete: Doble EP con bolsillo de aluminio
productividad: 100kg/month
transporte: Ocean,Air
Lugar de origen: Hebei, China
Apoyo sobre: 100kg/month
Certificados : ISO9001
Hafen: Shanghai
Tipo de Pago: L/C,T/T
Incoterm: FOB,CIF
Niraparib es un inhibidor de PARP de molécula pequeña oralmente activa desarrollado por Tesaro para tratar el cáncer de ovario.
Niraparib se usa para el tratamiento de mantenimiento de pacientes adultos con ovario epitelial recurrente, trompa de Falopio o cáncer peritoneal primario que están en respuesta completa o parcial a la quimioterapia basada en platino.
|
Test Items |
Specification |
Test Results |
|
Appearance |
White powder |
White powder |
|
Melting point |
125~127°C |
Conforms |
|
Specific Rotation |
+28°~+30° |
+29° |
|
Acidity(PH) |
5.2~6.5 |
5.8~6.2 |
|
Water |
4.0%~5.5% |
5.0% |
|
Residue On Ignition |
Not more than 0.1% |
Conforms |
|
N.N - dimethylaniline |
Comply with the standard |
Conforms |
|
Phenolic Compounds |
Comply with the standard |
Conforms |
|
Related Substance |
Comply with the standard |
Conforms |
|
Assay |
Between99.0~102.0% |
99.53% |
|
Conclusion |
This batch is complies with USP 41 |
|
PRODUCTOS POR GRUPO : API e intermedios > APIS en polvo
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now